ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/24 | 1,645 | 1,754 | 1,645 | 1,704 | +59 | +3.6% | 1,733,600 |
| 2024/07/23 | 1,630 | 1,656 | 1,625 | 1,645 | +8 | +0.5% | 387,800 |
| 2024/07/22 | 1,627 | 1,641 | 1,606 | 1,637 | +17 | +1% | 440,100 |
| 2024/07/19 | 1,640 | 1,649 | 1,620 | 1,620 | -14 | -0.9% | 399,900 |
| 2024/07/18 | 1,660 | 1,696 | 1,619 | 1,634 | -36 | -2.2% | 945,800 |
| 2024/07/17 | 1,665 | 1,684 | 1,663 | 1,670 | +21 | +1.3% | 458,300 |
| 2024/07/16 | 1,669 | 1,684 | 1,646 | 1,649 | -31 | -1.8% | 709,700 |
| 2024/07/12 | 1,638 | 1,690 | 1,634 | 1,680 | +25 | +1.5% | 915,500 |
| 2024/07/11 | 1,677 | 1,677 | 1,633 | 1,655 | -12 | -0.7% | 749,000 |
| 2024/07/10 | 1,692 | 1,700 | 1,653 | 1,667 | -13 | -0.8% | 739,300 |
| 2024/07/09 | 1,633 | 1,681 | 1,632 | 1,680 | +61 | +3.8% | 976,900 |
| 2024/07/08 | 1,622 | 1,638 | 1,613 | 1,619 | +11 | +0.7% | 330,600 |
| 2024/07/05 | 1,625 | 1,638 | 1,605 | 1,608 | +3 | +0.2% | 351,400 |
| 2024/07/04 | 1,642 | 1,646 | 1,605 | 1,605 | -36 | -2.2% | 412,900 |
| 2024/07/03 | 1,590 | 1,641 | 1,590 | 1,641 | +62 | +3.9% | 681,800 |
| 2024/07/02 | 1,565 | 1,586 | 1,562 | 1,579 | +11 | +0.7% | 487,200 |
| 2024/07/01 | 1,607 | 1,609 | 1,561 | 1,568 | -35 | -2.2% | 590,300 |
| 2024/06/28 | 1,609 | 1,615 | 1,600 | 1,603 | -9 | -0.6% | 464,600 |
| 2024/06/27 | 1,621 | 1,671 | 1,609 | 1,612 | +7 | +0.4% | 1,240,400 |
| 2024/06/26 | 1,580 | 1,639 | 1,578 | 1,605 | +17 | +1.1% | 859,500 |
| 2024/06/25 | 1,566 | 1,601 | 1,566 | 1,588 | +42 | +2.7% | 757,600 |
| 2024/06/24 | 1,518 | 1,562 | 1,511 | 1,546 | +39 | +2.6% | 572,800 |
| 2024/06/21 | 1,519 | 1,540 | 1,506 | 1,507 | -12 | -0.8% | 389,700 |
| 2024/06/20 | 1,495 | 1,527 | 1,494 | 1,519 | +24 | +1.6% | 386,700 |
| 2024/06/19 | 1,526 | 1,533 | 1,488 | 1,495 | -24 | -1.6% | 505,900 |
| 2024/06/18 | 1,535 | 1,545 | 1,519 | 1,519 | -13 | -0.8% | 320,500 |
| 2024/06/17 | 1,523 | 1,534 | 1,498 | 1,532 | -1 | -0.1% | 456,600 |
| 2024/06/14 | 1,527 | 1,550 | 1,521 | 1,533 | -2 | -0.1% | 466,500 |
| 2024/06/13 | 1,566 | 1,566 | 1,520 | 1,535 | -28 | -1.8% | 433,700 |
| 2024/06/12 | 1,533 | 1,572 | 1,515 | 1,563 | +18 | +1.2% | 838,000 |
| 2024/06/11 | 1,516 | 1,559 | 1,513 | 1,545 | +28 | +1.8% | 961,600 |
| 2024/06/10 | 1,522 | 1,528 | 1,496 | 1,517 | +3 | +0.2% | 410,200 |
| 2024/06/07 | 1,502 | 1,521 | 1,486 | 1,514 | +12 | +0.8% | 448,200 |
| 2024/06/06 | 1,510 | 1,528 | 1,497 | 1,502 | +6 | +0.4% | 558,700 |
| 2024/06/05 | 1,500 | 1,504 | 1,476 | 1,496 | -3 | -0.2% | 605,100 |
| 2024/06/04 | 1,450 | 1,507 | 1,445 | 1,499 | +59 | +4.1% | 834,100 |
| 2024/06/03 | 1,448 | 1,456 | 1,432 | 1,440 | -12 | -0.8% | 568,400 |
| 2024/05/31 | 1,403 | 1,452 | 1,403 | 1,452 | +56 | +4% | 615,700 |
| 2024/05/30 | 1,375 | 1,412 | 1,374 | 1,396 | +3 | +0.2% | 955,200 |
| 2024/05/29 | 1,428 | 1,433 | 1,393 | 1,393 | -41 | -2.9% | 496,800 |
| 2024/05/28 | 1,434 | 1,455 | 1,425 | 1,434 | +5 | +0.3% | 414,800 |
| 2024/05/27 | 1,408 | 1,438 | 1,404 | 1,429 | +15 | +1.1% | 465,000 |
| 2024/05/24 | 1,420 | 1,449 | 1,414 | 1,414 | -26 | -1.8% | 623,300 |
| 2024/05/23 | 1,431 | 1,473 | 1,422 | 1,440 | +29 | +2.1% | 855,300 |
| 2024/05/22 | 1,383 | 1,428 | 1,379 | 1,411 | -2 | -0.1% | 1,001,000 |
| 2024/05/21 | 1,440 | 1,451 | 1,398 | 1,413 | -57 | -3.9% | 1,903,600 |
| 2024/05/20 | 1,460 | 1,514 | 1,459 | 1,470 | +2 | +0.1% | 961,500 |
| 2024/05/17 | 1,514 | 1,514 | 1,468 | 1,468 | -52 | -3.4% | 1,096,400 |
| 2024/05/16 | 1,515 | 1,537 | 1,514 | 1,520 | +19 | +1.3% | 540,000 |
| 2024/05/15 | 1,567 | 1,594 | 1,501 | 1,501 | -61 | -3.9% | 959,700 |
251～
300
件表示中 / 5144件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 92,300円 | +20.3% | - | 0.00% | 163.65倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 154,300円 | -2.4% | -52.3% | 3.69% | 18.47倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 223,600円 | +4.1% | -3.1% | 2.59% | 19.42倍 | 1.69倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ハートシード | 355,500円 | +174.2% | - | 0.00% | - | 10.76倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ＪＣＲファーマ | 60,000円 | +14.3% | - | 3.33% | 24.39倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
